![Alliance News](https://static.lse.co.uk/images/news-logos/alliance-news-logo.png)
AIM WINNERS & LOSERS: Brighton Pier profit surges on strong summer
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.
Read moreWed, 02nd Feb 2022 12:40
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.
Read more(Sharecast News) - The Sunday Times's Lucy Tobin tipped shares of neuroscience outfit Cambridge Cognition Holdings to readers.
Read moreCambridge Cognition jumps on GBP2.1 million clinical trial contract
Read moreAIM WINNERS & LOSERS: AFC gets Extreme E boost; Chamberlin raises cash
Read moreTRADING UPDATES: Petropavlovsk expects lower output; Keywords robust
Read more(Sharecast News) - Brain health technology company Cambridge Cognition has been awarded contracts for two clinical trials by an unnamed "top 20" pharmaceutical company, it announced on Monday, to assess the pro-cognitive effects of a new drug in schizophrenia.
Read moreCambridge Cognition wins assessment contracts for schizophrenia drug
Read moreIN BRIEF: Cambridge Cognition wins second GBP500,000 contract
Read moreTRADING UPDATES: Omega disputes repayment; BWA applies for licenses
Read moreEXECUTIVE CHANGES: CFOs drop like flies; ex-IG CEO to chair Scotgold
Read moreTRADING UPDATES: East Star makes buy; Kromek wins USD17 million deal
Read more(Sharecast News) - Digital brain health technology company Cambridge Cognition has secured a contract for a further sizeable schizophrenia trial with an existing customer, it announced on Tuesday.
Read moreTRADING UPDATES: Cambridge Cognition in profit; PensionBee loss widens
Read moreUK earnings, trading statements calendar - next 7 days
Read more